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1.2 Summary of thesis 
Introduction
The increasing prevalence of asthma seen worldwide during the last decades has in some 
recent reports shown a levelling off. Asthma has been associated with reduced lung function 
both in childhood, adolescence and adulthood and reduced lung function in infancy has been 
identified as a risk factor for lower respiratory illness in the first years of life. However, the 
association of impaired lung function early in life to obstructive airway disease later in life is 
still unsettled. Likewise is our knowledge of which factors influence lung function 
development from birth into childhood limited.  The main aim of the present thesis was to 
explore the overall association between lung function and asthma through childhood and the 
specific research questions were: 
I. What is the prevalence of asthma among school children in Oslo? 
 II.  Is lung function reduced in children with asthma? 
III.   What factors are associated with lung function development through 
childhood? 
IV. Is lung function at birth associated with lung function later in childhood? 
V. Is lung function at birth associated with asthma later in childhood? 
 
Methods
The present thesis reports results from the prospective birth cohort “the Environment and 
Childhood Asthma (ECA) Study” in Oslo established in 1992. At birth 3754 term infants 
were enrolled and a representative sub sample of newborns had lung function measurements 
by tidal flow volume loops (n=802) and passive respiratory mechanics (n=664) at mean 2.7 
days (± S.D. 0.9). Starting at the maternity ward, extensive questionnaires were completed by 
the parents every six months the first two years of life. Cohort children with recurrent 
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bronchial obstruction (rBO) the first two years of life (n=306) together with age matched 
controls without any episodes of bronchial obstruction were recruited to a nested case-control 
study with a clinical examination, including lung function measurements by tidal flow volume 
loops, at two years of age. The two years assessment was attended by 516 children, of whom 
140 children had lung function measured at birth.   
Of the 1019 children attending a 10 year follow-up study including lung function 
measurements, bronchial provocation tests, skin prick tests and a structured interview, 616 
children had lung function measurements at birth. The latter group of children was 
representative for the general cohort at birth, and was suitable for prevalence studies.  
 
Results
At 10 years of age the life time prevalence of asthma was 20.2% and 11.1% had current 
asthma. Children with current asthma had reduced tPTEF/tE at birth and reduced FEV1 and 
FEF50 at 10 years. Asthma ever was associated with reduced tPTEF/tE and Crs at birth.  
Lung function development from birth to two years of age was not influenced by the 
presence of atopic eczema or rBO by two years whereas current asthma and maternal smoking 
during pregnancy were significant predictors for FEF50 even after adjusting for lung function 
at birth. Lower respiratory tract infections during the first two years of life did not 
significantly influence lung function development from birth to 10 years of age.  
tPTEF/tE  at birth correlated reasonably well with tPTEF/tE at two years of age and 
tracking of lung function the first two years of life was found to be present, independent of the 
expression of  allergic diseases. Crs at birth was significantly associated with FEV1 at ten 
years and tPTEF/tE at birth was a significant predictor of FEF50 at 10 years. 
Children with both rBO and AE by two years, a high-risk phenotype for atopic 
diseases in school age, had significantly reduced tPTEF/tE both at birth and at two years of age. 
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Reduced lung function at birth was found to be a risk factor for asthma ever by 10 years as 
well as current asthma at 10 years with an adjusted odds ratio of about 2. In a high-risk group 
of children with Crs< median and tPTEF/tE <0.20 the prevalence of asthma ever was 45.5% and 
current asthma 28.1%, respectively. 
 
Discussion
The reported prevalence of asthma is the highest ever in Norway and indicates a substantial 
increase compared to surveys in the mid nineties. The findings of reduced lung function in 
children with current asthma at the age of 10 years are in line with several previous studies, 
but this is the first report of reduced lung function at birth in children with asthma in school 
age. 
Lung function at two years of age was associated with lung function at birth, but not 
with concurrent allergic disease expression. Lung function at 10 years was associated with 
lung function at birth, maternal smoking during pregnancy and current asthma at ten years, 
but not with lower respiratory tract infections the first two years of age These results suggest 
that, although lung function development through childhood may be modulated by lower 
respiratory tract disease and environmental factors, tracking is present from the very 
beginning of extra uterine life. 
The novel finding of reduced lung function at birth as a risk factor for asthma in 
childhood differs from the few previous studies addressing this issue. The Perth study found 
an association to wheeze, but not to asthma in school aged children. This discrepancy may be 
due to methodological differences based in type of lung function measurements at birth as 
well as the sample size in the ECA study being several times larger than all other studies to 
date with this focus. Our results point to factors that have already in utero exerted an effect 
that is implicated in asthma development in a subpopulation of children. These children at 
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risk may be identified by the reduced lung function present at birth, although such 
measurements are unlikely to be valuable for individual subject prediction. 
Conclusions
In conclusion the results presented in the present thesis indicate that the prevalence of 
childhood asthma has increased substantially since the mid nineteen-nineties. Asthma is 
associated with reduced lung function both at birth and at 10 years of age and although some 
factors may modulate lung function development during childhood, tracking of lung function 
is dominant through childhood and starts very early in life. Reduced lung function at birth is a 
risk factor for asthma through childhood pointing to pre natal factors being implicated in the 
development of asthma in some children.  
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1.3 Abbreviations 
AE   Atopic eczema 
AHR   Airway hyper responsiveness 
BO   Bronchial obstruction 
Crs   Compliance of the respiratory system 
CV   Coefficient of variation 
tPTEF/tE  Change in tPTEF/tE from birth to two year of age 
DDA   Doctors diagnosed asthma 
ECA-1   The Environment and Childhood Asthma Study part 1 
ECA-2   The Environment and Childhood Asthma Study part 2 
FEF50   Forced expiratory flow at 50% of forced expiratory volume 
FEF25-75 Mean forced expiratory flow between 25%-75% of forced expiratory 
volume 
FEV1   Forced expiratory volume in 1 second 
FEV1/FVC  Ratio of forced expiratory volume in 1 second to forced vital capacity 
FEV0.5   Forced expiratory volume in 0.5 second 
FEV0.75  Forced expiratory volume in 0.75 seconds 
FRC   Functional residual capacity 
FVC   Forced vital capacity 
ISAAC  International Study of Asthma and Allergy in Childhood 
LRIs   Lower respiratory tract infections 
OR   Odds ratio 
Pj   Mean jacket inflation pressure 
PW   Persistent wheeze 
 (rho)   Spearmans two tailed correlation coefficient 
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rBO   Recurrent bronchial obstruction 
Rrs   Resistance of the respiratory system 
RTC technique Rapid thoracoabdominal compression technique 
RV/TLC  Ratio of residual volume on total lung capacity  
sGaw   Specific airway conductance  
SPT   Skin prick test 
tPTEF/tE   Ratio of time to peak tidal expiratory flow to total expiratory time 
V’max,FRC  Maximal expiratory flow at functional residual capacity
VPTEF/VE  Volume expired at peak tidal expiratory flow on total expired volume 
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2. GENERAL INTRODUCTION 
2.1. Asthma in childhood 
2.1.1 Definitions and phenotypes 
Our understanding of bronchial asthma has evolved tremendously since the first description in 
the Hippocratic (460-370 B.C.) writings (1). The term asthma, derived from the ancient Greek 
word for panting, was for more than 2000 years mainly used as description of symptoms: 
episodes of laboured, rapid breathing with wheeze, chest tightness and coughing. The 
attempts to define the disease were likewise largely based upon symptoms. However, as our 
understanding of the physiology of the airways and the pathophysiology of asthma has 
improved new features of the disease have been added to the definition. However, no strict 
definition of asthma has been agreed upon and the Global Initiative for Asthma (GINA) has 
changed to the term “operative description” when describing asthma:  
 
“…a chronic inflammatory disorder of the airways in which many cells and cellular elements 
play a role. The chronic inflammation is associated with airway hyperresponsiveness that 
leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, 
particularly at night or in the early morning. These episodes are usually associated with 
widespread, but variable, airflow obstruction within the lung that is often reversible either 
spontaneously or with treatment” (2). 
This “operative description” describes the pathology (chronic inflammation), 
physiological features (airway hyperresponsiveness (AHR) and variable airflow obstruction) 
and symptoms (wheezing, breathlessness, chest tightness and coughing) associated with 
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asthma. From a paediatric and epidemiological point of view this description has two major 
limitations.  
First, this description may in many ways be useful in diagnosing and monitoring 
asthma in school age children, adolescent and adults as both airway inflammation, AHR and 
airflow obstruction can be measured. However, measurement of these objective features in 
preschool children is more difficult and partly unreliable, and the underlying pathological and 
physiological features of asthma are less explored in this age group. Attempts have therefore 
been made to approach this issue in a more pragmatic manner. The “Nordic consensus report 
on asthma management” states that “the diagnosis of asthma can be strongly considered in 
the following circumstances:” 
 
“1. From the third attack of airway obstruction during the last year is current asthma. 
2. One attack of asthmatic symptoms occurring after the age of 2 years. 
3. Irrespective of age in an attack in children with eczema, food allergy or other allergy. 
4. If the child does not become free of symptoms when infection has ceased, or has persistent 
symptoms for more than a month”(3).
 
In the “Third International Pediatric Consensus Statement on the Management of 
Childhood Asthma”, asthma among children younger than three years is defined as:  
 
“.....recurrent wheezing and/or persistent coughing in a setting where asthma is likely and 
other rarer conditions have been excluded” (4). 
 
  These two latter definitions have in common that the diagnosis of asthma is based 
upon clinical judgement and not on objective measures. 
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The second and most important limitation of the GINA “operative description” is that 
the described features do not apply to all subjects with asthma. No single feature is universal 
or unique to asthma. The dominant cells of inflammation vary as bronchial biopsies from 
patients with allergic asthma showed no correlation between AHR and the number of 
different inflammatory cells (5), but an eosinophilic inflammation was associated with 
reduced lung function (5). Others have found patients with severe asthma to have a 
predominance of neutrophilic inflammation in their bronchial mucosa (6).  Population studies 
have shown AHR to be present in schoolchildren not reporting respiratory symptoms or 
having diagnosed asthma (7-9) and in patients with allergic rhinitis, but who do not have 
asthma (9-11). On the other hand, studies examining AHR in wheezing preschool children did 
not find the same response to airway challenge tests as in older children and adults (12;13). It 
is well known that asthmatic patients often have normal lung function between attacks, even 
among patients with severe asthma reduced lung function is not a consistent finding. (14-16). 
The symptoms associated with asthma are likewise not unique to patients with asthma but 
may be caused by several other conditions especially in children (17).  
This heterogeneity in the “asthma population” and the overlap in airway 
characteristics between those with and those without asthma have increased the uncertainty of 
epidemiological studies of asthma, making it more difficult to interpret result of prevalence 
studies and especially to analyze time trends and compare results from different geographical 
areas. 
In order to explain the heterogeneity among asthmatic patients, attempts have been 
made to define phenotypes with different characteristics, but who fit under the “asthma 
umbrella”. Among children the phenotypes have been created to explain the different natural 
history of- (18;19) and to predict the prognosis of early life wheezing (20). In the Tucson 
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birth cohort study the children were “phenotyped” at six years as no wheezing (never 
wheezed), transient early wheezing (wheezing before the age of three, but not at six years), 
late onset wheezing (wheezing at six years, but not before three years of age) or persistent 
wheezing (wheezing both before the age of three years and at six years) (18). In this 
retrospective perspective cord serum IgE levels were unrelated to wheezing phenotype, but 
compared to children who had never wheezed the children with persistent wheezing had 
significantly higher IgE level at nine months of age and at six years. They also had a 
significantly higher prevalence of positive skin test reactivity as was the case among the late 
onset wheezers at six years of age (18). Lung function measurements showed the transient 
early wheezers to have reduced maximal expiratory flow at functional residual capacity
(V’max,FRC) at birth and the transient early wheezers as well as the persistent wheezers to have 
reduced V’max,FRC at six years of age (18).  
At 11 years of age, after a re-examination including measurements of peak flow 
variability and bronchial challenge testing, the Tucson investigators defined three wheezing 
phenotypes in children (19): Transient early wheezers associated with reduced lung function 
at birth that persists through childhood; Non-atopic wheezers associated with increased peak 
flow variability long after the wheezing symptoms had ceased. The third group was the IgE-
associated wheeze/asthma that may exist at any age during childhood and was related to the 
combination of atopy, increased responsiveness to metacholin and increased peak flow 
variability.  This was in line with the phenotypes previously described by Wilson (21) with a 
hypothetical prevalence as shown in figure 1. 
In the German Multicenter Atopy Study (MAS study), a prospective birth cohort 
study, four phenotypes were defined based upon the presence or not of wheeze and atopic 
eczema (AE) by two years of age (20). Children with both wheeze and AE by two years were 
characterized by a specific sensitization pattern (sensitization to less prevalent allergens) at 
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two years, a high risk of current wheeze at seven years and reduced lung function at seven 
years compared to children without wheeze and AE by two years thereby representing a high 
risk group for asthma in school age (20).  
Figure 1. Hypothetical yearly peak prevalence of wheezing for the three different wheezing 
phenotypes in childhood. Reprinted with permission from Stein et al. Thorax 1997; 52(11): 
946-952. 
However, none of the described phenotypes represent distinct entities, and there is a 
substantial degree of overlap in the clinical expression as the severity of the symptoms as well 
as the underlying pathology and physiological features between the phenotypes. 
2.1.2. Epidemiology 
Global trends 
During the last decades the prevalence of asthma has shown an almost epidemic increase in 
the western world (22). The increase, which was first reported among children (23), has been 
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associated with western life style and urbanization (24-28). The prevalence rates show a wide 
variation world wide as shown by the International Study of Asthma and Allergy in 
Childhood (ISAAC) (29). This study, using a validated and translated standardized 
questionnaire at different study centres in different parts of the world, found an approximately 
20-fold difference in prevalence of asthma symptom between the countries with the highest 
figures (Great Britain, Australia and New Zealand) and those with the lowest figures 
(Albania, Indonesia), figure 2 (29). Earlier studies have shown an east-west gradient within 
Europe in prevalence of asthma symptoms (30;31) and this gradient was also apparent in the 
ISAAC study (29). 
However, several more recent studies report a levelling off or even a decrease in 
asthma prevalence (32-35), all from westernized countries where previously high prevalence 
rates have been reported. Other studies from western-Europe (36-39), eastern-Germany (40) 
and Australia (41) report no change in the trends of asthma prevalence. The results are 
conflicting and even studies from the same country show discrepancies (32;41). This 
divergent trend in asthma prevalence is also reflected in the phase three of the ISAAC study 
(42), a follow up at mean seven years after the initial phase. Although the mean prevalence of 
asthma symptoms in young children (six-seven years of age) increased, there was a wide 
variety with several centres, especially in the western world, showing a levelling off and even 
a decrease in the prevalence of asthma. Among older children (13-14 years of age) there was 
no increase the mean asthma prevalence and the divergence was even more pronounced (42). 
There is however one major limitation to much of the epidemiological research among 
asthma in children: The definition of asthma. Most studies use the symptom of wheeze as a 
surrogate for asthma, but this symptom may represent other airway abnormalities than 
asthma. In a study assessing the prevalence of wheeze, asthma and other airway diseases in 
Sweden, Finland and Estonia the prevalence of wheeze was highest in Estonia, but the 
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reported prevalence of asthma far lower than in the Scandinavian countries (43). Furthermore, 
in most countries outside the English speaking ones the term wheeze does not exist as such 
and a standardization of translation has thus been challenging.  
 
 
Figure 2. 12-month prevalence of self-reported asthma symptoms among 13-14 years old 
children from written questionnaires in the International Study of asthma and Allergy in 
Childhood (ISAAC) Phase I study. Reprinted with permission from the ISAAC Steering 
Committee, Lancet 1998; 351 (9111): 1225-1232.
 21
National trends 
The first report of asthma prevalence among school age children in Norway was by Claussen 
in 1948 (44), who reported a prevalence of 0.4%. Later studies have reported steadily higher 
prevalences, figure 3. Although direct comparison between the first (1948, 1954 and 1978) 
(44-46) and the latest studies (47-52) is difficult as different questionnaires were used, the 
studies in 1981, 1993 and 1994 (50-52) included the same questionnaires and were all 
conducted in Oslo. In the latest study conducted in 1994 a prevalence of 9.3% was reported 
(52), the highest  reported thus far in Oslo.  Contemporary studies from Northern Norway 
(12.3%) (47) and Mid-Norway (10.2%) (49) report comparable prevalence, while a study 
from West-Norway (53) reported a lower prevalence (5.4%). However, all these studies report 
lower prevalences of asthma than studies from many other western European countries (29). 
 
 
Figure 3. The prevalence of asthma in Norway 1948-1994. Studies marked with a dot has 
applied identical questionnaires. Reprinted with permission from Carlsen KH, Tidsskr Nor 
Laegeforen 2001; 121(7):836-840. 
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2.2. Lung function during childhood 
2.2.1. Historical aspects 
The works by Erasistratus (c. 280 BC) and Galen (129-201) demonstrating the role of the 
diaphragm as a muscle of respiration, the origin and function of the phrenic nerve and the 
function of the intercostal and the accessory muscles has been regarded as the earliest studies 
on lung function (54). The knowledge of the respiratory system, including anatomical aspects, 
the role of ventilation in maintaining life and gas exchange evolved slowly thereafter for 1500 
years. The birth of respiratory physiology as such took place in the seventeenth century (54). 
Borelli measured in 1679 the maximal volume of a single inspiration (54) and in 1846 
Hutchinson defined vital capacity as “the greatest voluntary expiration following the deepest 
inspiration”, designed the first spirometer for its estimation and reported it to be related to the 
height of the person (54). Measurement of residual volume by gas dilution technique was first 
introduced by Davy in 1800 (55). Although the gas dilution technique has been modified 
several times thereafter, the basic principle of equilibrium between the air in the lung and a 
known volume of an insoluble inert gas is still used in the assessment of  lung volumes. 
 In 1950  “Standardization  of Definitions and Symbols in Respiratory Physiology” 
was published by leading American respiratory physiologists defining the various volumes 
and its abbreviations (56) still used today as described in figure 4. The use of whole body 
plethysmography for the measurement of lung volumes and airway resistance was introduced 
by DuBois and colleagues in 1956 (57). About a century after Hutchinson developed the 
spirometry, a rotating drum was added, enabling measurement of absolute volume expired or 
inspired in a given time (e.g. FEV1) and the rate of change of volume with time (i.e. flow 
rates) (55). 
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Figure 4. Total lung capacity and its subdivisons. Reprinted with permission from SJ Bourke. 
Lecture Notes in Respiratory Medicine, 7th edition 2007. Blackwell Publishing 
 
Knowledge of the control of respiration evolved after the observation that a lesion in 
medulla oblongata interfered with normal breathing reported in the first part of the nineteenth 
century (54). Based upon the findings by Hering and Breuer 50 years later that this region 
received information about distension of the lung via the vagus nerve, the understanding of 
the self-regulation mechanism evolved. The exploration of the role of hypoxemia and 
hypercapnia, as  well as the exploration and understanding of the muscle spindles in 
respiratory muscles and pulmonary receptors contributed  to increased understanding of this 
regulatory mechanism (54). 
2.2.2. Methods of lung function measurement in infants and children 
The progress in our understanding of respiratory physiology has been followed by a 
concurrent advance in methods and equipment for lung function measurements both for 
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research and clinical purposes. However, most of these methods have been developed for use 
in adults and later been modified for use in children mature enough for the cooperation 
necessary to perform most of these tests.  
For lung function measurement in infants and young children who are unable to 
cooperate adequately, several methods have been developed. Both measurement by tidal flow 
volume loops, passive and dynamic respiratory mechanics, forced expiration by the forced 
deflation technique or the rapid thoracoabdominal compression (RTC) technique, whole body 
plethysmography and gas dilution techniques have been applied in the assessment of infant 
lung function (58). However, due to insufficient standardization of most of these techniques, 
they have mainly been used for research purposes, and no “gold standard” for infant lung 
function has been agreed upon. 
Lung function measurement by tidal flow volume loops was first described in 1957 
(59). In 1981 Morris and Lane published a study comparing the shape of the flow to time and 
flow to volume curves in obstructed and healthy subjects during tidal breathing (60). They 
reported a significant correlation between the ratios of time to peak tidal expiratory flow to 
total expiratory time (tPTEF/tE) and volume expired at peak tidal expiratory flow to total 
expired volume (VPTEF/VE) and FEV1, FEV1/FVC and airway resistance among adults (60). 
In infants measurements by tidal flow volume loops are made with the infant lying 
supine, awake or asleep, quietly breathing (61;62). Noise, tactile stimuli and other factors that 
may influence the breathing pattern of the infant must be reduced to a minimum as it is of 
great importance that the infant has a natural, reproducible and regular breathing pattern. A 
flow meter, usually a pneumotachograph, is attached to a face mask with a “putty” kept tight 
with a minimal pressure over the mouth on the infant to ensure no air leak (61). As for other 
techniques of lung function measurements in infants the dead space and the resistance of the 
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equipment must be reduced to a minimum. A sampling rate of  200 Hz is recommended 
when measuring tPTEF/tE, for other parameters a lower sampling rate may be sufficient (61).  
Although a minimum number of 10 consecutive stable cycles ( 30 seconds recording) are 
recommended for analysis (63) previous studies have reported 4-50 cycles with various 
standardization criteria (64-66). The recently published recommendations for tidal flow 
measurements in infants can also be applied in older children with a few modifications (63): 
The children should be awake and sitting and a mouthpiece may be applied instead of a face 
mask.   
Although several parameters have been calculated from tidal breathing (67) most 
studies report tPTEF/tE or VPTEF/VE which have shown to correlate well with each other (60). 
These ratios are usually calculated by the computer software based upon a time flow plot as 
shown in figure 5 for tPTEF/tE (62). Although it is still unsettled what the tidal flow volume 
ratios exactly represent, it is assumed that “timing of PTEF is due to an interaction between 
the mechanical properties of the lungs and airways on one hand and central control of 
breathing on the other” (63). tPTEF/tE has been used to discriminate between infants and 
children with and without obstructive airway disease in several studies (60;64;66;68) and 
documented the effect of -2 agonist inhalation in young children (64;66;69) although there 
has been a considerable overlap. Measurements of tPTEF/tE has been shown to be reproducible 
(65;70) and the coefficient of variation (CV) has in most studies but one (65) been about 25% 
(60;66;70;71). In infants parameters of tidal flow volume measurement have correlated poorly 
with lung resistance (72), respiratory resistance (73) and specific airway conductance (68), 
but reasonably well with V’max,FRC (68;74). However, in older children significant correlation 
was found between tPTEF/tE and FEV1 and forced expiratory flow at 50% of forced expiratory 
volume (FEF50) with a correlation coefficient of about 0.5 (60;66;75).  
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Figure 5. Flow time plot for tidal breathing parameters. PTEF/PTIF: Peak tidal 
expiratory/inspiratory  flow. tE: expiratory time. tPTEF: time to reach PTEF. tI: inspiratory time 
tPTIF: time to reach PTIF. Reprinted with permission from Carlsen KCL, Carlsen KH: 
Paediatric Pulmonary Function Testing. Prog Respir  Res. Basel, Karger, 2005, vol 33, pp 10-
19. 
 
Indices of respiratory mechanics may be assessed by passive or dynamic measurement 
in infants (76). Dynamic measurements are performed during spontaneous breathing (with the 
respiratory muscles actively contracting) and allow assessment of the different components of 
the respiratory system, but will not be discussed in detail here. In contrast to dynamic 
respiratory mechanics measurements, passive respiratory mechanics measurements give 
information about compliance and resistance of the entire respiratory system by the single or 
multiple occlusion technique, with the single occlusion technique being the most applied 
method and will be discussed in more detail (76). Measurements are performed with the 
infant lying quietly breathing with a slight extension of the neck. A face mask, held tightly 
over the infant’s mouth and nose, is connected to a flow meter. (77). Between the face mask 
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and the flow meter a shutter/valve with a pressure port connected to a pressure transducer 
with a range of ±5 kPa is included. Data acquisition starts after a stable tidal respiration has 
been achieved, verified on a real time display. At end inspiration the shutter is closed and due 
to the Hering Breuer Inflation reflex the respiratory muscles will relax and pressure 
equilibrium in the respiratory system (from the alveoli to the mouth) will be reached as there 
is no flow (77). The occlusion is sustained until pressure equilibration has occurred (a 
pressure plateau with change of pressure < 20 Pa for 100 ms). Pressure is measured at the 
airway opening at equilibrium and flow is measured at a sampling rate of 200 Hz. The flow 
volume curve obtained upon opening the shutter, fig 6, is used for calculation of compliance 
of the respiratory system (Crs) and resistance of the respiratory system (Rrs) as well as time 
constant of the respiratory system (trs).  
 
Figure 6. Flow volume curve obtained following end inspiratory occlusion for the single 
occlusion technique. V’ext: extrapolated flow. Vext: extrapolated volume. V1: Volume at time 
of occlusion. trs: time constant. Vx: intersection of trs with volume axis. VEEL: End expiratory 
lung volume. Veocc: volume at end expiration. Vic: difference between Vx and Veoc. 
Reprinted with permission from Gappa et al. Eur Respir J 2001; 17: 141-148. 
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Crs is calculated as change in (extrapolated) volume to change in pressure from 
opening of shutter to end of expiration (Crs=Vext·Poa-1), Rrs as change in pressure to 
change in flow (extrapolated) (Rrs=Poa· V’ext-1) and trs is given by the product of Crs and 
Rrs (trs=Crs·Rrs) (77). Criteria for acceptable measurements are in addition to the criteria for 
pressure plateau, smooth expiration to within 10% of previous expiration and linearity of at 
least 40% of the flow volume curve. A mean of three to five acceptable manoeuvres should be 
reported (77).  
Measurement of infant lung function by the RTC technique was first introduced by 
Adler and Wohl in 1978 (78). This technique, which allows measurements of forced 
expiration in uncooperative infants and children, has later been improved by Taussig and 
coworkers (79). The infants must be sedated, lying in a supine position with a tight face mask, 
connected to a flow meter, covering the mouth and nose (80). The dead space of the 
equipment should be kept to a minimum and measures must be taken to ensure no air leak in 
the system (81). The recommended sampling rate for data acquisition for RTC measurement 
is 200 Hz as for tidal breathing measurements (81). The infant to be assessed wears a 
“squeeze jacket” with an inflatable inner layer wrapped tightly around the thorax, abdomen 
and upper thighs (80;81). After a stable end expiratory functional residual capacity (FRC) 
level has been achieved through 5-10 stable tidal loops the “squeeze jacket” is inflated at end 
tidal inspiration and the pressure is maintained through the entire forced expiration (81). Each 
curve is accepted or rejected according to given criteria (81), assessed by means of a real time 
display of inspiratory and expiratory volumes, mean jacket inflation pressure (Pj), airway 
pressure and flow volume curve. The procedure is repeated until the minimal Pj (optimal 
pressure) necessary to obtain maximal flow at FRC is discovered. The optimal pressure is 
then used to perform 3-5 partial expiratory flow volume curves for calculations of mean 
V’max,FRC (mL·s-1) (81) as shown in figure 7.  
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V’max,FRC is thought to represent the function of the small peripheral airways (79) and 
RTC measurement have been applied in a number of epidemiological, clinical and 
physiological studies (80), but no widely accepted reference material is available. The high 
variability in reported V’max,FRC from different centres is probably due to the lack of reliable 
volume landmark for measurement of V’max,FRC as FRC varies according to respiratory rate, 
degree of sedation and airway calibre (80).  
 
 
Figure 7. Partial expiratory flow volume curve obtained by rapid thoracoabdominal 
compression technique for calculation of maximal expiratory flow at functional residual 
capacity (V’max,FRC) in a healthy infant and an infant with bronchiolitis. PEF: Peak expiratory 
flow. FRC: Functional residual capacity. Reprinted with permission from Modl M, Eber E: 
Paediatric Pulmonary Function Testing. Prog Respir Res. Basel, Karger, 2005, vol 33, pp 34-
43. 
 
Forced expiratory flow volume measurement (spirometry) is the most commonly used 
lung function test in children able to cooperate. It is widely used both in clinical practice and 
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for research purposes and internationally updated guidelines for preschool children (63) as 
well as older children and adults (82) are available. The child should be sitting and the 
procedure carefully described. A successful measurement depends on total cooperation from 
the child, and a trained and dedicated technician (83). A mouthpiece is connected to a 
flowmeter, usually a pneumotachometer. The procedure starts by full inhalation to total lung 
capacity follow by forceful expiration to residual volume for a minimum of 3 seconds in 
children younger than 10 years of age and minimum 6 seconds in children 10 years or older 
(82). Specific criteria for successful start and completion of the manoeuvre have been agreed 
upon (82) and in children an interactive computer animated system may be helpful as many 
children have problem fulfilling these criteria (63). According to guidelines, three acceptable 
manoeuvres should be achieved (82), and both flow volume and volume time curves should 
be displayed for evaluation. The most common parameters derived from forced expiratory 
flow volume measurement are FVC, FEV1, FEV1/FVC, FEF50 and forced expiratory flow at 
25%-75% of FVC (FEF25-75). Spirometry is reproducible in well cooperating children. Several 
studies have addressed acceptability and reproducibility of spirometry among preschool 
children (84-90) and the latest ERS/ATS guidelines (63) conclude that criteria for successful 
measurements in adults were not appropriate in preschool children. Only two acceptable 
manoeuvres are sufficient, and forced expiratory volume in 0.5 (FEV0.5) as well as 0.75 
(FEV0.75) seconds should be reported.  
2.2.3. Lung function development 
In the embryo the lung bud develops during the fourth week of development. The lung bud 
soon divides into the primary bronchial buds which enlarge to form the two main bronchi. By 
24 weeks approximately 17 generations of subdivisions have been formed, and a further 7 
orders of airway development form during postnatal life (91). At 24 weeks of gestation the 
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terminal sacs are present making gas exchange possible. Primordial alveoli are present from 
about 32 weeks, but characteristic mature alveoli develop mainly after birth (91). 
From birth until three years of age lung volume increases mainly due to an increasing 
number of alveoli, however alveoli may still develop up to age eight years (91;92). Thereafter 
increase in lung volume is mainly due to expansion of the alveoli (92) with a 13 fold increase 
in total lung volume from the prenatal period until seven years of age (93). The increase 
continues thereafter until early adult age with varying speed. Several studies have shown that 
the growth spurt of the lungs is out of phase with that of the body (94-97) and the lung growth 
continues after the height growth has ceased (97). The relative distribution between the 
different “sub volumes of the lung” changes also by ages as the ratio of residual volume to 
total lung capacity (RV/TLC) increases by age (98).  
In contrast to the alveoli, the number of conducting airways is complete at birth and 
thereafter increase only in size (92), with the peripheral airways increasing relatively more 
than the proximal airways (99). After multiplication of alveoli is complete, lung growth is 
assumed to be isotropic, meaning that lung size and airway size develop symmetrically 
(92;97;100).  
Gender related airway size changes significantly during puberty. In infancy (101) and 
during childhood (102-105) girls have larger airways than boys for a given volume although 
the total height adjusted lung volume is larger in boys than girls already from early life (106). 
During puberty boys have a larger increase in airway size compared to lung size than girls 
(98) resulting in a shift with males having higher maximal flows than females in adulthood 
(107;108). 
The phenomenon of tracking, meaning the predictability of future values by early 
measurements (109), has been shown to be a characteristic of lung development. Dockery and 
coworkers reported in 1983 that in children 6-11 years tracking in lung function was nearly as 
 32
great as tracking in height (tracking index, , >0.90) when evaluating FEV1 and FVC (110). 
This finding has later been confirmed for several indices of lung function measurement both 
in childhood and in adolescent (111). In the Dunedin study, tracking was found to be present 
from childhood into adulthood and to be independent of symptoms of lower respiratory 
disease (112). However, the question of how early tracking begins has been unsettled. 
Tracking has been reported in the neonatal period measured by tidal flow volume loops (70), 
in the first nine months of age in low birth weigh infants as well as in infants with normal 
birth weight measured by the raised volume RTC  technique (113), and in the first year of life 
in preterm children without neonatal respiratory disease (114). Furthermore, significant 
correlation was found for tPTEF/tE (Spearmans two tailed correlation coefficient () 0.423) and 
specific airway conductance (=0.374) measured at eight weeks and one year of age (115). 
On the other hand an Australian study found that tracking was not consistent through the first 
year of life neither when V’max,FRC, tPTEF/tE or Crs were evaluated (116). Studies reporting 
longitudinal results of lung function from early childhood into school age are divergent. In the 
Perth study children with persistent wheezing (PW) until 11 years of age had reduced lung 
function shortly after birth using the RTC technique, at six years and at eleven years, but for 
other wheezing phenotypes there was no significant trend of tracking (117). This is in contrast 
to the Tucson study, using the same technique for lung function measurement, reporting 
children with PW to have reduced lung function at six years only while transient early 
wheezers had reduced lung function both at six years and shortly after birth (18). Follow up 
studies at 11 and 16 years confirmed that tracking was evident from school age into 
adolescence independent of wheezing phenotype (118). However, further support to the 
hypothesis that tracking starts early in life comes from a longitudinal study in children with 
bronchopulmonary dysplasia reporting a high correlation between V’max,FRC at two years and 
FEV1 and FEF25-75 in school age (119).  
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2.2.4 Factors associated with lung function growth 
Although tracking of lung function has been demonstrated during most of the “lung growth 
period”, several factors have been associated with lung function abnormalities. Maternal 
smoking during pregnancy has been associated with reduced lung function at, or shortly after 
birth (120-122) as has a family history of asthma, maternal hypertension during pregnancy 
(120) and maternal respiratory tract infections during pregnancy (123). The effect of antenatal 
maternal smoking on lung function has been shown to be sustained through the first year of 
life in a study with repeated lung function measures (124) as well into later childhood in 
several studies (125;126). Cross-sectional (125-128) as well as in longitudinal studies 
(129;130) of exposure to second hand smoke during pre school- as well school age have 
demonstrated a significant negative effect on lung function. 
Active asthma in childhood is associated with reduced values of forced flow (FEV1, 
FEF25-75, and FEV1/FVC) both in males and females (128;131-134) on a group level, but most 
studies fail to show an impact on lung volume (FVC) (128;131;133). This is in line with the 
results of longitudinal studies including children with asthma (133;134) and/or repeated 
measurements of AHR (97;133;135). A reduced growth of airway size was found as indicated 
by less increase of indices of airway flow in children with asthma and/or AHR. Lung volumes 
were either not affected (97;134;135) or  slightly increased (133) indicating that asthmatics 
have a non-isotropic growth of lung function. However, none of the studies included 
preschool children and only one study (134) included children younger than 8 years of age. 
Lower respiratory tract infections (LRIs) early in life have in several studies been 
associated with reduced forced flow values, but not lung volume, both in school age (136-
140) and in adulthood (141-143). Pneumonias (139;141;142), no-pneumonia LRIs (139), 
bronchitis (137) as well as undefined LRIs (136;138;140;143) have been reported to give 
impaired lung function later in life. However, most of these studies have a retrospective 
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design and do not control for lung function early in life prior to the potential insult by the 
airway pathogen. Neither has the microbial airway pathogen causing the LRIs been identified 
in most of these studies. Other studies have found an association between Respiratory 
syncytial virus (144-147) as well as Mycoplasma pneumonia (148;149) infections in early life 
and subsequent reduced lung function . 
During recent years several longitudinal studies (150-155) have confirmed the 
negative impact of air pollutants on lung growth previously reported from cross sectional 
studies (156-158). The effect has been on both forced flow values as well as on lung volumes. 
In two large longitudinal studies the magnitude of the effect of air pollution exposure on lung 
growth was found to be similar (150) or slightly greater (151) than the effect of exposure to 
maternal smoking. A recently published study reported a reduced growth in lung function 
from school age into early adult age in children living within 500 meters from a motorway 
(159). However, although the studies are consistent in their finding of a detrimental effect on 
lung function development there is still controversy on which pollutant (ozon, particulate 
matter with a diameter less than 10 μm and 2.5 μm, nitrogen dioxide acid vapour, organic 
carbon and elemental carbon) is most harmful as varying effect have been found in different 
studies. However, air pollution will not be further discussed in any detail in the present thesis. 
2.2.5. Early lung function as a predictor of obstructive airway diseases later in life 
The first report of an association between reduced lung function early in life, before any 
symptoms of respiratory illness, and subsequent increased risk of lower respiratory diseases 
came from the Tucson pediatric study in 1988 (160).  Infants with wheezing during the first 
year of life had reduced tPTEF/tE and respiratory conductance (sGaw) at about two months of 
age prior to any symptoms of lower respiratory disease. At a follow up study by six years of 
age it was found that children with transient early wheezing (see section 2.1.1 for definition) 
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had reduced V’max,FRC at birth and at six years of age whereas children with persistent 
wheezing had reduced V’max,FRC at six years only (18). The findings from Tucson have later 
been confirmed in several studies: Children reporting wheeze the first year of life had reduced 
tPTEF/tE, sGaw and increased airway resistance in the first week of life (161). Reduced 
V’max,FRC at one month of age was found in children who wheezed during the first year(s) of 
life in unselected populations (162;163) as well as in an atopic high risk population (164). In 
one study stratifying into “wheeze groups” (first year only, second year only, both first and 
second year) showed all “wheeze groups” to have reduced  V’max,FRC at one month, but only 
children who wheezed both the first and second year to have reduced Crs compared to never 
wheezers (163).  Reduced tPTEF/tE early in life has similarly been associated with increased 
risk of recurrent bronchial obstruction (rBO) (165) and doctors diagnosed asthma (116) by 
two years of age.  
Although most studies find an association between impaired early life lung function 
and symptoms of obstructive airway disease in the first years of life the associations to 
obstructive lower airway diseases later in life is less clear. In the Perth cohort reduced 
V’max,FRC at one month of age was associated with persistent wheeze (PW) until 11 years of 
age and recent wheeze at 11 years but not doctors diagnosed asthma by 11 years of age (117). 
This is in contrast to the results from the Tucson cohort reporting children with PW to have 
reduced lung function at six, 11 and 16 years of age but not at 2 months of age (118). 
However, due to differences in definition of PW, the studies are not entirely comparable. 
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3. AIMS OF THE PRESENT STUDY 
The overall objective of the studies included in the present thesis was to determine the overall 
association between lung function and asthma through childhood. 
The specific research questions were: 
 I. What is the prevalence of asthma among school children in Oslo? 
 II.  Is lung function reduced in children with asthma? 
III.   What factors are associated with lung function development through 
childhood? 
IV. Is lung function at birth associated with lung function later in childhood? 
V. Is lung function at birth associated with asthma later in childhood? 
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4. METHODS AND SUBJECTS 
4.1. Design of study 
The present thesis reports results from the prospective birth cohort study the Environment and 
Childhood Asthma (ECA) Study part 1 (ECA-1) and 2(ECA-2), figure 8. The ECA study was 
established January the 1st 1992 as a collaborative study between Department of Pediatrics at 
Ullevål University Hospital and Section for Epidemiology at National Institute of Public 
Health. At the maternity wards of the two municipal hospitals in Oslo and 3.754 (75% of all 
eligible) infants were recruited at birth during the 15 months inclusion period according to the 
following criteria. 
 Inclusion criteria: 
o Birth weight more than 2000 grams 
o Absence of any illness likely to impair respiration (severe respiratory, 
cardiovascular, neuromuscular or metabolic disease) 
o No requirement for assisted ventilation or oxygen therapy after beyond 6 hours 
after birth 
Exclusion criteria: 
o Plans to move out of Oslo the next six months 
o Insufficient language comprehension by the parents to be able to complete 
questionnaires 
Before leaving the maternity ward (mean age (± SD) 2.7 (0.9) days) lung function 
assessments were performed in 802 infants at the largest maternity ward at Ullevål University 
Hospital by tidal flow volume loops and passive respiratory mechanics . 
 
 38
Figure 8. Simplified study design of the Environment and Childhood Asthma Study. ECA-
1/ECA-2: Environmental and Childhood Asthma Study part 1/part 2. Blue boxes: ECA-1. 
Green Box: ECA-2. Red boxes: Children with lung function measurements at birth. 
 
Starting at the maternity ward, parents of the children completed extensive half yearly 
questionnaires until two years of age. A nested case-control study was established with cases 
identified by these questionnaires and clinical registration cards with doctors documenting 
signs of bronchial obstruction (BO) as well as direct referrals from well baby clinics, hospital 
admissions and family doctors. A case was a child with rBO defined by at least two episodes 
of BO or BO lasting more than 4 months before two years of age. At least one episode of BO 
had to be confirmed by a doctor. The controls were the children without BO born closest in 
time to the case. The defined 306 cases and 306 controls were invited to a clinical assessment 
at enrolment if younger than 20 months of age and all cases and controls were invited to 
clinical assessment at two years (mean age 25 months) including lung function measurement 
Included n=3754 
 Birth 
2 yrs
10 yrs
Lung function 
n=802 
ECA-1  
ECA-2  
 
n= 140 
Case-control 
516/612 
 
 
Follow u
n=616 
p 1019/1215 
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by tidal flow volume loops before and after inhalation of salbutamol, skin prick test, blood 
samples and a structured interview. A total of 562 children attended at least one of the 
assessments of whom 516 children (265 cases, 251 controls) attended the two year visit.  
At ten years of age all traceable children who had attended at least one of the clinical 
visits the first two years of life and/or had lung function measurements at birth were invited to 
a follow up study (ECA-2). One thousand and nineteen of the 1215 eligible children (84%) 
attended the two days of examination (within a week) including forced expiratory flow 
volume measurements on both days, measurements of bronchial hyperresponsiveness by 
metacholine challenge test and exercise test by a treadmill run, skin prick test, measurement 
of fractioned exhaled nitric oxide, collection of blood samples, urine samples and dust from 
the child’s mattress and an extensive interview of the parent(s) to be filled out by the study 
doctor. All personnel involved in the data collection in ECA-2 were blinded to the results of 
the assessments in ECA-1. 
4.2. Subjects 
Paper 1, 2 and 4: 
The study population of these three papers include the 616 children (332 boys, 284 girls) with 
lung function measurements at birth who attended the 10 year follow up study (mean age 
(SD), 10.9 ( 0.9) years).  Sufficient information was available to classify 614 children for 
asthma ever/history of asthma and 606 for current asthma, for definitions see section 4.4. 
These 614 children (614 with lung function measurement by tidal flow volume loops and 500 
by passive respiratory mechanics) are included in paper 1 and 2. They did not differ in 
baseline characteristics compared to the remainder of the entire cohort of 3.754 infants, but 
were slightly longer and heavier at birth compared to the 188 children with lung function at 
birth who did not participate in the 10 year follow up, table 1.  
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Table 1. Baseline characteristics of subjects included in paper 1 and 2 compared to the 
remainder of the ECA study population.   
 
Characteristics
Children included in 
the follow up study 
n=614 
Children not included in the 
follow up study 
n=3140
Lung function at birth 
 yes  (n=194)     no (n=2946)
Gender (% boys) 53.7 51.6 51.0 
Birth weight (kg)   3.59 (0.49) 3.50 (0.48)* 3.55 (0.51) 
Birth length (cm)  50.5 (2.2) 50.2 (2.2)** 49.7 (3.6) 
tPTEF/tE 0.32 (0.11) 0.31 (0.11) NA 
Compliance of the respiratory 
system (ml·cmH2O-1.kg)  
4.16 (1.19) 4.08 (1.17) NA 
Parental asthma (%) 12.0 12.3 12.2 
Parental rhinoconjunctivitis (%) 29.7 27.4 27.2 
Maternal smoking in pregnancy  
             daily or occasionally (%) 
 
24.8 
 
30.6 
 
24.4 
 
Values are given as mean ± S.D or per cent when stated. NA denotes not applicable. Parental 
refers to mother, father or both. *p=0.03, **p= 0.04 compared to children included in the 
follow up. Reproduced with permission from Håland et al, N Engl J Med 2006; 355: 1682-
1689. 
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Paper 4 includes 607/616 children attending the 10 year follow up with lung function 
measurements at birth, information of lower respiratory tract infections the first two years of 
life and successful lung function measurement at 10 years. Mean age was 10.9 ( 0.8) years, 
and among these there was no significant differences in baseline characteristics compared to 
the 195 children with lung function measurements at birth not included in the study. 
 
Paper 3 
The study population of paper 3 comprises the135 children included in the nested case control 
study with lung function measurements at birth (135 by tidal flow volume loops and 117 by 
respiratory mechanics), information about rBO and AE by two years and attendance in the 
two year assessment. They had more often parents with rhinoconjunctivitis (37.8% vs. 27.4%, 
p=0.016) but did otherwise not differ in baseline characteristics compared to the 667 children 
with lung function measurements at birth not included in the study.  Ninety children had 
successful lung function measurements at two years. 
4.3. Methods 
Parental questionnaires/interviews 
The half yearly questionnaires and the parental standardized interview at the two year 
assessment included questions about symptoms of lower respiratory disease and atopic 
diseases, use of anti-asthmatic medication, lower and upper respiratory infections, exposure of 
the child to tobacco smoke during intrauterine life and the first two years of life and 
respiratory and atopic diseases in parents and siblings. 
At the ten year follow up the parents responded to an extensive interview completed 
by the study doctor, including core ISAAC questions about symptoms of lower respiratory 
diseases validated in Norwegian (166), having a doctors diagnosis of asthma, use of anti 
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asthmatic medication, atopic diseases in 1st degree relatives, infections, socioeconomic and 
home environmental issues, physical activity and diet. Environmental factors were to some 
extent assessed in detail, but will not be further discussed in the present thesis. 
 
Lung function measurements 
At birth 802 awake infants had lung function measurements by tidal flow volume loops and 
664 by passive respiratory mechanics lying on the investigators lap (167). At two years of age 
lung function was measured by tidal flow volume loops in children free of lower respiratory 
tract symptoms sitting on the lap of a parent. Short acting -2 agonists were withheld since 
the day before (none used long acting -2 agonists) and theophyllamins and antihistamins for 
72 hours.  
Flow was measured using a pneumotachograph with a flow range of 0-10 lmin-1 at 
birth (8311 series, Hans Rudolph, Missouri, USA) and 0-30 lmin-1 at 2 years (4500 series, 
Hans Rudolph, Missouri, USA) attached to an appropriate face mask with an air inflated cuff 
to make it closely fitting to the face of the child, ensuring no air leak. The dead space of the 
system was 2.4 ml (8311 series) and 3.2 ml (4500 series) respectively, and that of the face 
masks was 8.5-11ml (167). Volume was calculated by the digital integration of the flow 
signal with a frequency of 256 samplessec-1. tPTEF/tE was calculated by separate 
measurements of the time to peak expiratory flow and total expiratory time by the software 
programme of the computer of the SensorMedics 2600 System (SensorMedics Corp., 
Anaheim, CA, USA). The flow and volume signal were calibrated daily by a 100 ml precision 
syringe (Hans Rudolph, Missouri, USA). 
The reported result for each child is the mean of four representative curves chosen 
from of eight loops stored on the computer. These eight curves were obtained from a series of 
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breaths with as stable volume and shape of the loops as possible and as low respiratory rate 
possible.  
Respiratory system mechanics were measured in the newborn babies using the single 
breath, passive occlusion technique (167). A stable baseline level was established through 
several tidal cycles followed by an airway occlusion created by an automatic slide valve. The 
occlusion was sustained until equilibrium between alveolar and airway pressure was obtained 
i.e. a pressure plateau with variation <±0.125 cm H2O for 100 ms was recorded by the 
computer. The passive expiratory flow-volume loop obtained upon opening the slide valve 
was registered and used for measurement Crs (ml·cmH2O-1) and calculation of resistance of 
the respiratory system (Rrs) (cmH2O·ml-1·s). The reported results are the mean of the accepted 
curves (range 2-14) obtained for each infant. 
At ten years lung function was measured by forced expiratory flow volume loops 
according to the European standard (168). Long acting -2 agonists, theophyllamines and 
leukotrienantagonists were withheld for 72 hours, antihistamins for 5 days, short acting -2 
agonists for 8 hours and inhaled cortocisteroids the same day, respectively. Baseline lung 
function was measured on two occasions before challenge testing within a week at least four 
weeks after any symptoms of LRIs by trained and experienced technicians using a Sensor 
Medics Vmax 20c (SensorMedics Diagnostics, Yorba Linda, CA, USA). FEV1, FEF50 and 
FVC are reported as percent predicted based upon the reference values of Zapletal (169) and 
FEV1/FVC as absolute value from the best of the two baseline measurement.  
Assessment of airway hyperresponsiveness 
At the ten year follow up study AHR was assessed by a direct method (metacholin challenge 
test) and indirect method (exercise challenge) within a week, both at least four weeks after 
any symptoms of lower respiratory tract disease. Long acting -2 agonists, theophyllamines 
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and leukotrienantagonists were withheld for 72 hours, antihistamins for 5 days, short acting -
2 agonists for 8 hours and inhaled cortocisteroids the same day, respectively.  
Metacholin challenge test was performed according to ATS Guidelines (170) by 
inhaling doubling doses of metacholin nebulized by the inhalation triggered Spira Dosimeter 
(Spira Respiratory Care Center Ltd, Hämeenlinna, Finland) until a fall in FEV1 of 20 percent 
(metacholin provocation dose) or the maximal dose of metacholin (22.4 mol) was reached. 
Exercise challenge test was performed by treadmill running 6-8 minutes without 
preceding warm-up according to a standardized protocol (171). Effort was made to reach a 
heart rate of 95% of maximum (220-age) the last 4 minutes of the running. Lung function was 
measured before and three, six, 10, 15 and 20 minutes after the test. A test was regarded 
positive with a 10% or more decrease in FEV1 3-20 minutes after the running. 
Skin Prick Tests 
Skin prick test (SPT) was performed according to the Nordic standard (172) at the two year 
assessment to the following standardized allergens (Greer laboratories INC, Lenoir, NC, 
USA): egg white, cows milk, dermatophagoides pteronyssinus, timothy grass, cat dander, dog 
dander, silver birch, mugwort and Cladosporium herbarum. Histamine 10mg/ml was used as 
positive control and saline as negative control. A test was considered positive with a wheal of 
half the size of the positive control. 
At ten year SPT was performed to the following 15 common allergens (Soluprick®, 
ALK, Abello, Denmark): House dust mites (Dermatophagoides (D.) pteronnysinus and D. 
farinae), german cockroach, dog, cat, and rabbit dander, birch, timothy (grass) and mugwort 
pollens, moulds (Cladosporium herbarium and Alternaria alternata), egg white, milk, peanut 
and codfish. The test was performed according to international standard (173) with a positive 
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test to a specific allergen defined as a mean wheal diameter 3mm larger than the negative 
control (0.9%NaCl). 
4.4. Definitions and outcomes 
Asthma ever (paper I) and history of asthma (paper II) was defined by fulfilling at least two of 
the following three criteria:  
1. Dyspnoea, chest tightness and/or wheezing 0-3 years and/or 4-10 years 
2. Doctor’s diagnosis of asthma ever 
3. Use of asthma medication (ß-2 agonsist, sodium chromoglycate, corticosteroids, 
leukotriene antagonists and/or aminophylline) 0-3 years and/or 4-10 years 
Current asthma (paper I, II and IV) was defined as asthma ever/history of asthma plus at least 
one of the following criteria:  
1. Dyspnoea, chest tightness and/or wheezing during the last 12 months 
2. Use of asthma medication (ß-2 agonist, sodium chromoglycate, corticosteroids, 
leukotriene antagonists and/or aminophylline) during the last 12 months 
3. Positive exercise test at the ten year follow up 
 
Wheeze ever (paper I) was defined by a positive response to the questions “Has your child 
experienced dyspnoea, chest tightness and/or wheezing during the age periods 0-3 years 
and/or 4-10 years?” 
 
In paper III the four clinical phenotypes were defined by the presence or not of AE and rBO 
the first two years of life: no rBO or AE, AE only, rBO only and both AE and rBO. 
 
Severe AHR in paper II was defined as a metacholin provocation dose of less than 1 mol. 
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4.5. Statistical analyses 
Baseline characteristics are given as mean values with standard deviation (SD) or per cent 
when stated. Results are given as mean with 95% confidence interval unless otherwise stated. 
For continuous variables differences between unpaired groups were assessed using the two 
sample t-test assuming normal distribution and a one-sample t-test was used to compare 
paired variables. Categorical variables were compared using the Pearson’s Chi-Square test.  
Multiple groups were compared using one-way analysis of variance (ANOVA), or the non 
parametric Kruskal-Wallis tests when appropriate. Tukey’s Post Hoc test was used when the 
ANOVA analyses indicated a significant difference between groups. Pearson’s coefficient of 
correlation was used to assess possible associations.  
Level of agreement between tPTEF/tE at birth and two years of age was assessed by 
Weighted Kappa () given by lung function categorized at the two time points (paper III). 
A two sided p-value of 0.05 was considered statistical significant. Analysis were performed 
with  Statistical Package for Social Sciences version 11.0 (paper II) version 12.0 (paper I) and 
version 14.0 (paper III and IV) for Windows (SPSS, Chicago, IL, USA) and Statistical 
Analysis System version 9.1.13 (SAS, Cary, NC USA) in paper III. 
 
Categorization of lung function 
Based upon lung function measurements at birth for all 802 children according to tPTEF/tE and 
664 according to Crs the children were categorized into quartiles to evaluate lung function 
development from birth to two years of age (paper III). The middle two quartiles were merged 
since possible differences are more likely to occur between extreme values. Change in lung 
function from birth to two years of age (tPTEF/tE) was calculated as tPTEF/tE at two years 
minus tPTEF/tE at birth. 
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To assess changes in lung function from birth to ten years of age (paper IV) z-scores 
were calculated based upon mean and SD calculated at birth for all children (as they were 
healthy at the time) and at 10 years for all children without any LRIs the first two years of life 
and without a history of asthma. Changes in lung function were calculated as z scores at ten 
years minus z-scores at birth.  
Cut off values of lung function at birth for calculation of risk of a history of asthma 
and current asthma at ten years in paper II were based upon commonly used statistical 
approaches of median values, as well as the previously identified clinical cut-off of  tPTEF/tE 
<0.20 (165).
 
Regression analysis 
Logistic regression analyses were performed to estimate odds ratio (OR) for asthma ever and 
current asthma in paper I including gender, allergic sensitisation and parental history of 
allergic disease (asthma and/or rhinoconjunctivitis) as covariates. In paper II the logistic 
regression analyses assessing OR for a history of asthma and current asthma included gender, 
maternal smoking in pregnancy, birth length, birth weight and parental asthma and parental 
rhinoconjunctivitis reported at birth of the index child. In addition, OR for Crs was also 
adjusted for tPTEF/tE 0.20, and ORs for tPTEF/tE were adjusted for Crs <median. 
To asses possible predictors of lung function (tPTEF/tE) at two years and change in lung 
function from birth to two years of age (tPTEF/tE) in paper III a multiple linear regression 
model was created including maternal smoking during pregnancy, gender, clinical phenotype 
at two years, age in months at two years assessment, birth weight and birth length and 
parental asthma and parental rhinoconjunctivitis reported at birth of the index child as 
covariates. For tPTEF/tE as outcome tPTEF/tE at birth was included in the analysis as well. 
Similarly was lung function at ten years of age (i.e. FEV1, FEF50, FVC, FEV1/FVC) evaluated 
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(paper IV) using multiple linear regression analyses including current asthma at ten years, 
positive SPT to any allergen at ten years, parental asthma, parental rhinoconjunctivitis, 
maternal smoking during pregnancy, gender, tPTEF/tE, Crs, Rrs, parental asthma and parental 
rhinoconjunctivitis reported at birth of the index child and LRIs the first two years of life 
either categorized as pneumonia yes/no, bronchiolitis yes/no and bronchitis yes/no or 
summarized in total number of LRIs as independent variables. The final multivariate model 
was build as described by Hosmer and Lemeshow (174). For the significant predictors results 
are given as regression coefficient (B) with 95% CI and p-value and adjusted R2 are given for 
the final model. The influence of co-linearity was assessed using the variance inflation factor 
(VIF) and the Studentized deleted residuals were used to assess the normality of the model. 
Cook’s d was used to assess the influence of the single observations. 
 
Regression to the mean 
Controlling for “regression towards the mean” was performed for tPTEF/tE in paper III by 
taking the average of the initial and final measurement and calculating the correlation between 
this value and the observed change, as described by Altman (175) 
4.6. Ethical issues 
Written informed consent was obtained from parent(s) of all the included infants at the 
maternity ward before inclusion in the ECA study. Renewal of the consent was obtained at 
enrolment into the 10 follow up study after written information to the parents as well as the 
child. The participants were informed that they could withdraw from the study at any time. 
The study was approved by the Norwegian Data Inspectorate and the local Committee for 
Medical Ethics made no objections to the study. The study was registered in the Norwegian 
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Biobank Registry, Ullevål University Hospital in Oslo. 
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5. RESULTS OF THE STUDIES 
5.1. Prevalence of asthma among school children in Oslo 
In the ten year follow up study 20.2% of the children fulfilled the criteria of asthma ever and 
11.1% the criteria of current asthma (paper I). Doctors diagnosis of asthma was reported in 
16.1% of the children and 30.6% reported wheeze ever. Current asthma and wheeze ever were 
more frequent among boys than girls (14.4% vs 7.1%, p=0.008 and 36.9% vs 22.5%, p=0.002 
respectively) but boys and girls did not differ significantly with respect to asthma ever (22.9% 
vs 17.0%, p= 0.086) and doctors diagnosed asthma. Similar numbers of children reported 
wheeze before four years of age (8.8%) and at age 4-10 years of age (9.1%) whereas 12.6% 
reported wheeze both before and after the age of four years. 
Compared to no asthma children and asthmatic children without current symptoms, 
children with current asthma were characterized by a higher prevalence of positive SPT 
(56.1% vs 26.0% in no asthma children and 26.8% in asthma children without current 
symptoms, p<0.001) and parental asthma and/or rhinoconjunctivitis (67.2% vs 49.1% and 
49.6% respectively, p<0.024) reported at ten years (paper I).  
5.2. Lung function in children with asthma 
Lung function was reduced both at birth as well as at 10 years in children with asthma. 
Children with current asthma at 10 years had significantly lower values of FEV1 and FEF50 
compared to children with no asthma and asthmatic children without current symptoms, table 
2 (paper I). Children fulfilling the criteria of a history of asthma as well as current asthma had 
reduced tPTEF/tE and Crs (although not statistical significant for the current asthma group) at 
birth compared to the no asthma group, table 2 (paper II). 
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Table 2. Lung function at birth and 10 years of age in children with and without asthma. 
 
 
No asthma Asthma, no 
current symptoms 
Asthma ever P value Current asthma P value 
tPTEF/tE  0.322  
(0.312-0.332) 
__ 0.298 
0.278-0.317 
0.03 0.293 
0.266-0.321 
0.05 
Crs 4.241 
 (4.125-4.356) 
__ 3.876 
(3.639-4.114) 
0.005 3.942 
(3.614-4.270) 
0.08 
FEV1 99.1 
98.3-100.0 
100.3 
(97.7-102.8) 
__  95.8 
(93.3-98.3) 
0.021 
FEF50 91.0 
(89.4-92.7) 
86.7 
(82.1-92.1) 
__  79.0 
(73.8-84.0) 
<0.001 
 
Values are given as mean with 95% confidence interval for tPTEF/tE and Crs measured at birth 
and FEV1 and FEF50 measured at ten years. For tPTEF/tE and Crs p values are given for 
comparison with no asthma group, for FEV1 and FEF50 p values are given for trend. 
 
5.3. Factors associated with lung function development through childhood 
Lung function development from birth to two years of age measured by tPTEF/tE was not 
influenced by the presence of AE and/or rBO (paper III), figure 9. In a multiple linear 
regression model including maternal smoking during pregnancy, gender, parental asthma, 
parental rhinoconjunctivitis, clinical phenotype at two years (presence of AE and/or rBO), age 
in months at two years assessment, birth weight, birth length and tPTEF/tE at birth as covariates 
only tPTEF/tE at birth was significantly associated with tPTEF/tE from birth to two years of age 
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when this covariate was introduced. In the final model including 90 subjects, the explained 
variability of tPTEF/tE (R2=0.353, p<0.001) was then mainly explained by tPTEF/tE at birth.  
 
Figure 9. Lung function measured by tidal flow volume loops (mean ± 95% confidence 
interval) at birth and two years of age according to clinical phenotype by 2 years.  
rBO: recurrent bronchial obstruction. AE: atopic eczema. Reprinted with permission from 
Håland et al Pediatr Allergy Immunol 2007; 18: 528-534. 
 
Reported bronchiolitis, bronchitis and three or more LRIs the first two years of life 
were associated with reduced FEF50 at ten years of age. Likewise was bronchiolitis associated 
with reduced Crs and tPTEF/tE at birth. However, after stratifying for gender these associations 
were found in girls only (paper IV). 
LRIs the first two years of life were not significantly associated with impaired lung 
function development from birth to 10 years of life, figure 10. Neither pneumonias, 
bronchitis, bronchiolitis or the total number of LRIs were predictors of any lung function 
indices at ten years of age when included in a linear regression model together with parental 
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rhinoconjunctivitis, parental asthma, maternal smoking during pregnancy, gender, current 
asthma at ten years, positive SPT to any allergen at ten years, and lung function at birth 
(tPTEF/tE, Crs and Rrs). For FEF50 the significant predictors were current asthma (B=9.47, 
4.70-14.24, p<0.001), male gender (B= 6.72, 3.74-9.70, p<0.001), maternal smoking during 
pregnancy (B=3.51, 0.073-6.95, p=0.045) and reduced tPTEF/tE at birth (B= 14.86, 1.43-28.30, 
p=0.03), but the adjusted R2 was poor (0.075).  
Controlling for the same factors for each gender separately left only current asthma at 
ten years as significant predictor of reduced FEF50 at ten years when including total numbers 
of LRI the first two years of life (Girls B=14.22, 5.87-22.56, p=0.001. Boys B=7.93, 2.05-
13.82, p=0.008). 
 
Figure 10. Change in lung function (mean with 95% confidence interval) by z-scores from 
birth (by tPTEF/tE) to 10 years of age (by FEF50) for reported bronchiolitis, bronchitis, 
pneumonia and total number of reported lower respiratory tract infections (LRIs) the first two 
years of age. p> 0.1 for all groups compared to no LRIs. Reprinted with permission Håland et 
al. Pediatr Allergy Immunol. In press. 
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5.4. Lung function from birth to ten years 
 Children with  tPTEF/tE in the lowest quartile at birth had significantly lower tPTEF/tE at two 
years of age compared to the upper quartiles (0.22 (0.18-27) vs. middles 0.27 (0.24-0.30), and 
upper 0.35 (0.31-0.38) respectively, overall p<0.001). The tPTEF/tE at birth correlated 
significantly with tPTEF/tE at two years, (r=0.475, p<0.001), and the measure of agreement was 
=0.42 (0.26-0.58, p<0.001). Rrs and Crs at birth were not significantly associated with 
tPTEF/tE at two years, but a weak correlation (r=0.11, p=0.003) was found between tPTEF/tE at 
birth and Rrs at birth, paper III. Only tPTEF/tE at birth (adjusted R2=0.23, p=0.001) was a 
significant predictor of tPTEF/tE at two year in a regression analysis including maternal 
smoking during pregnancy, gender, parental asthma, parental rhinoconjunctivitis, clinical 
phenotype at two years (presence of AE and/or rBO), age in months at two years assessment, 
birth weight, birth length and tPTEF/tE at birth as covariates, paper III. 
Although there was a significant difference in tPTEF/tE from birth to two years of age 
between the upper and lower tPTEF/tE birth quartile, this difference was no longer significant 
after controlling for regression to the mean, paper III.  
At ten years children with tPTEF/tE below mean at birth had significantly lower FEF50 
compared to children with tPTEF/tE above mean, and children with Crs below compared to 
above median at birth had significantly lower FEV1 compared to children with Crs above 
median, table 3 (paper II). 
tPTEF/tE at birth was a significant predictor for FEF50 at 10 years, as described in 
section 5.3., (paper IV). 
 
5.5. Lung function at birth and asthma later in childhood 
Children with clinical phenotype of rBO and AE at two years had lower tPTEF/tE at birth 
compared to children with no rBO or AE (0.28 (0.23-33) vs 0.34 (0.31-0.37), p=0.027), figure 
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9. Although not statistical significant, the children with this phenotype had the highest 
prevalence of positive SPT and use of inhaled corticosteroids, a marker of severity of 
obstructive airway disease, by two years, paper III. 
Compared to children with no asthma, children fulfilling the criteria of asthma 
ever/history of asthma had lower tPTEF/tE (0.30 (0.28-0.32) vs 0.32 (0.31-0.33), p=0.03) and 
Crs at birth (3.88 (3.64-4.11) vs 4.24 (4.13-4.36), p=0.005) as well as children with current 
asthma had lower tPTEF/tE (0.29 (0.27-0.32), p=0.05) an a trend towards lower Crs (3.94 (3.61-
4.27), p=0.08), paper II.  
Children with tPTEF/tE at birth below median were significantly more likely to have 
asthma ever as well as current asthma by ten years, table 3. tPTEF/tE below 0.20 at birth was 
significantly associated with increased prevalence of asthma ever, and children with Crs 
below median at birth had more often a history of asthma ever and current asthma by ten 
years, table 3. Severe airway hyperresponsiveness (metacholine provocation dose <1 μmol) at 
ten years was associated with tPTEF/tE <0.20 as well as below median at birth, table 3 (paper 
II). 
  Children with both tPTEF/tE<0.20 and Crs below median represented a high risk group 
for a history of asthma (45.5% vs 19.1%, p<0.001) and current asthma (28.1% vs 10.0%, 
p=0.002), figure 11 (paper II). 
After adjustment for gender, parental asthma, parental rhinoconjunctivitis and 
maternal smoking in pregnancy (ORs for Crs was also adjusted for tPTEF/tE 0.20, and ORs for 
tPTEF/tE were adjusted for Crs below median) tPTEF/tE <0.20 remained a significant risk factor 
for a history of asthma (OR 1.90 (1.06-3.42)) and a value of tPTEF/tE below median a risk 
factor for current asthma (2.10 (1.12-3.93)). Crs below median was a predictor for both 
asthma ever (OR 2.18 (1.39-3.38)) and current asthma (2.01 (1.10-3.66).
 
56
Ta
bl
e 
3.
 O
ut
co
m
es
 a
t t
en
 y
ea
rs
 o
f a
ge
 a
cc
or
di
ng
 to
 lu
ng
 fu
nc
tio
n 
m
ea
su
re
d 
at
 b
irt
h.
 
O
ut
co
m
es
 a
t 1
0 
ye
ar
s 
t P
T
E
F/
t E
t P
T
E
F/
t E
C
rs
 
<0
.2
0 
>0
.2
0 
p-
va
lu
e 
<m
ed
ia
n 
>m
ed
ia
n 
p-
va
lu
e 
< 
m
ed
ia
n 
>m
ed
ia
n 
p-
va
lu
e 
A
st
hm
a 
ev
er
 (%
) 
31
.3
18
.5
 
0.
00
7 
24
.3
16
.2
 
0.
01
3 
27
.4
14
.8
 
0.
00
1 
C
ur
re
nt
 a
st
hm
a 
(%
) 
14
.6
 
10
.5
 
0.
27
 
14
.6
7.
5 
0.
00
5 
15
.0
7.
7 
0.
00
9 
Se
ve
re
 A
H
R
 (%
) 
12
.7
 
5.
1 
0.
03
3 
9.
1 
4.
9 
0.
04
6 
5.
2
8.
9 
0.
11
1 
C
ur
re
nt
 u
se
 o
f I
C
S 
(%
) 
5.
3 
3.
9 
0.
49
 
5.
9 
2.
4 
0.
01
5 
5.
2
2.
7 
0.
10
3 
FE
V
1 
%
 p
re
di
ct
ed
 
m
ea
n,
 9
5%
 c
.i.
 
98
.9
 
96
.6
-1
01
.2
 
98
.9
 
98
.1
-9
9.
8 
>0
.5
 
98
.2
 
97
.1
-9
9.
4 
99
.6
 
98
.5
-1
00
.7
0.
08
7 
97
.8
96
.4
-9
9.
1
99
.7
 
98
.5
-1
00
.9
 
0.
03
4 
FE
F5
0 
%
 p
re
di
ct
ed
 
(m
ea
n,
 9
5%
 c
.i.
)  
88
.2
 
83
.8
-9
2.
7 
88
.6
 
88
.0
-9
1.
2 
>0
.5
 
87
.8
85
.6
-9
0.
0
91
.0
 
88
.9
-9
3.
1 
0.
03
9 
88
.3
 
85
.8
-9
0.
8 
90
.5
 
88
.1
-9
2.
8 
0.
22
2 
Se
ve
re
 a
irw
ay
 h
yp
er
re
sp
on
si
ve
ne
ss
 (A
H
R
): 
m
et
ac
ho
lin
 c
ha
lle
ng
e 
do
se
 <
1μ
m
ol
 th
at
 le
ad
s t
o 
a 
20
%
 re
du
ct
io
n 
in
 F
EV
1. 
R
ep
ro
du
ce
d 
w
ith
 
pe
rm
is
si
on
 fr
om
 H
ål
an
d 
et
 a
l, 
N
 E
ng
l J
 M
ed
 2
00
6;
 3
55
: 1
68
2-
16
89
.
 57
%
as
th
m
a 
tPTEF/tE tPTEF/tE
%
 c
ur
re
nt
a b
 
Figure 11. Prevalence of asthma ever (figure a) and current asthma (figure b) at ten years by 
tPTEF/tE below 0.20 and Crs below median at birth. 
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6. GENERAL DISCUSSION 
6.1. Prevalence of asthma among school children in Oslo 
The results of paper I of a lifetime prevalence of asthma of 20.2% and current asthma in 
11.1% of the children are the highest ever reported in Norway. The study indicate a 
substantial increase in prevalence of asthma among school children in Oslo compared to the 
1994 survey reporting a lifetime prevalence of asthma of 9.3% and current asthma in 5.5% of 
the children (52). These two studies are however not directly comparable due to 
methodological differences as lifetime prevalence of asthma was defined as doctors diagnosed 
asthma (DDA) in 1994. However, in our study DDA was reported in 16.1% which further 
support an increased asthma prevalence from the mid nineties.   
The findings in the ECA study are supported by a Danish study conducted in 2001 
reporting current asthma among 11.7% of school children living in Copenhagen, an urban 
population comparable to ECA population (36). In the Danish study current asthma had 
increased from 5.3% in a survey in 1986 applying the same questionnaire and a positive SPT 
to at least one out of 10 allergens among 46 % of the current asthmatics (36) compared to 
56.1% in the ECA study including 15 allergens. 
The results from the Norwegian Young-HUNT study, conducted in central Norway 
1995-97, differed from ours reporting current asthma, by the employed definition (DDA and 
wheeze last 12 months), in 8.5% of the girls and 7.1% of the boys (176). Current wheeze was 
reported among 29.0% of girls and 20.4% of boys. In another report from the same cohort, 
asthma prevalence was estimated to 14.7% (girls 18%, boys 11%) when defined as current 
wheeze and AHR (177), emphasizing the challenge of asthma labelling as previously 
discussed. However, these studies are not directly comparable to the ECA study due to 
methodological differences and the study population being older (13-16 years) meaning that 
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many of the included adolescents had gone through puberty, a period know to influence the 
prevalence of respiratory symptoms and asthma (178). 
In contrast to our study, several other studies have reported a levelling off or even a 
reduction in asthma prevalence (32-35). Most of these studies have however come from areas 
with a higher prevalence than reported in the previous Norwegian studies. This may lead to 
speculations that a “saturation level” of asthma prevalence has been reached in these areas, 
with their given genetic background and the present environment. However, for most of these 
studies the observation time has been rather short and they are based on questionnaires and do 
not include objective measures like assessment of AHR (33-35). These limitations are also 
valid for a northern Norway survey conducted in 2000 finding the life time prevalence of 
asthma (13.8%) to be unchanged from a similar study in 1995 in 9-11 year old children (179).  
Whether we are approaching a “saturation level” in Norway can only be determined by future 
surveys employing methods identical to previous studies. 
 
6.2. Lung function in children with asthma 
The presented result from paper I that school children with asthma have reduced mean forced 
flow values (FEV1 and FEF50) is in line with previous studies (128;131;132) including 
children from six years of age (131). The results from the two years assessment (paper III) of 
reduced lung function measured by tidal flow volume loops among children with both rBO 
and AE by two years of age, the more “severe” clinical phenotype with increased risk of 
wheeze and allergies in school age (20), adds further evidence to the association between 
asthma and reduced lung function. These findings raise the question whether the reduced lung 
function is due to impairment of lung function development in children with asthma or if it 
was present prior to disease expression; i.e. is reduced lung function a marker of increased 
susceptibility of asthma? 
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Lung function development in children with asthma 
In paper IV we report current asthma to be a significant predictor of lung function at ten years 
even when including lung function at birth in the analyses. Previous longitudinal studies 
assessing the impact of lower respiratory tract illness on lung function development from 
childhood into adolescent provide conflicting results. Decreased growth in airway calibre 
represented by reduced airflow values (FEV1, FEV1/FVC, FEF25-75), but not in lung volume 
(FVC) have been reported in children with AHR (97;135) or persistent asthma (180). Other 
studies find reduced lung function in children with lower respiratory tract illness already in 
early school age, but their further lung function development to be independent of lower 
respiratory tract illness (112;118;134;181). However, the latter studies did not include 
measurement of AHR and some studies stratified the children according to wheezing 
phenotype (112;118) as may represent, as previously discussed, other airway abnormalities 
than asthma. Furthermore, wheezing was relatively infrequent among many children, thus 
likely to have a mild disease only. Disease severity has previously been associated with level 
of AHR (182).  
The apparent paradox that current asthma at ten years predicted lung function at ten 
years (paper IV), but clinical phenotype by two years was not associated with lung function at 
two years (paper III) may be explained by the factors discussed above. At two years the 
children were categorized according to symptoms only and not by a diagnosis of asthma or 
the presence of AHR. Another possible explanation is that the duration of the disease had 
been too short to cause permanent impairment of lung function at two years of age, indicating 
that airway remodelling was not present. Assessment of airway remodelling is not the scope 
of the present thesis and objective measures of airway remodelling were not included in the 
ECA study. The issue will therefore not be further discussed.  
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However, only 90 children were included in the two years analyses which might have 
been to few to detect small, but real effects on lung function development the first two years 
of life by factors assessed. 
6.3. Other factors associated with lung function development 
The reduced lung function in school age in children reporting LRIs the first two years of life 
(paper IV) is in line with several previous studies (136-140). However, the novelty the ECA 
study is the possibility to adjust for lung function at birth in a large scale study. We could 
thereby conclude that lung function development from birth to ten years of age was not 
influenced by LRIs reported during the first two years of life (paper IV). Results from the 11 
year follow up of the Tucson birth cohort (139) support our conclusion as children with 
radiologically ascertained pneumonia as well as LRIs other than pneumonia in the first three 
years of life had reduced FEV1 and FEF25-75 at 11 years as well as reduced V’max,FRC at two 
months of age. However, the number of children with lung function measurements shortly 
after birth included was low and the finding of reduced lung function prior to any LRIs was 
not significant among the eight children with measurement of  V’max,FRC and X-ray confirmed 
pneumonia (139). In an Australian prospective study, children with bronchiolitis the first two 
years of life were found to have significant reduced V’max,FRC at one month of age as well as 
FEF25-75 at 11 years of age compared to children without bronchiolitis (183). The level of 
reduction in lung function was comparable at the two time points, but also in this study the 
sample size was small including only 16 children with bronchiolitis. Our results are further 
supported by several reports identifying reduced lung function during infancy as a risk factor 
for  wheezing lower respiratory illness during the first years of life (160-163;184) as 
wheezing in this age group is closely associated with LRIs.  
In paper IV LRIs were classified as pneumonias, bronchitis or bronchiolitis based 
upon doctors diagnosed disease reported by the parents in the questionnaires. In these 
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diagnostic entities there is a risk of misclassification due to the overlap in symptoms (185). 
However, in the study by Castro-Rodriguez and coworkers including chest X-rays to 
differentiate LRIs, both radiologically ascertained pneumonias as well as other LRIs the first 
years of life were associated with reduced lung function both in infancy and at 11 years of life 
(139). Thus our study, and others, do not support the hypothesis of a causal association 
between LRIs early in life and reduced lung function in school age, but rather points to initial 
reduced lung function as a risk factor or a marker of increased susceptibility to LRIs the first 
two years of life. However, we were not able to control for specific microbial airway 
pathogens involved in the LRIs as collecting microbial samples was not a part of our cohort 
study. Previous publications have found LRIs caused by Respiratory syncytial virus (139;144-
147) and Mycoplasma pneumonia (148;149) in early life to be associated with impaired lung 
function later in life. One may then speculate that some airway pathogens, independent of the 
clinical presentation, cause a small impairment of lung function not identified by our study. 
However, none of these previous studies report lung function measurements prior to the 
potential insult by the LRI.  
Maternal smoking during pregnancy has been associated with reduced lung function at 
birth (121) in our cohort, and in paper IV found to be a significant predictor of FEF50 at ten 
years of age even when lung function at birth was included in the regression analyses. 
Although the association just reached statistical significance (p=0.045) and was not evident 
when stratifying for gender, it is in line with previous studies (125;126). We did not control 
for exposure to second hand smoke in the first years or at ten years, but other studies have 
reported the effect of post natal exposure to be non significant when adjusted for in utero 
exposure (125;186). Although maternal smoking during pregnancy was not a significant 
predictor of lung function (by tPTEF/tE) at two years or tPTEF/tE, this may be due to the number 
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of children with lung function measurement both at birth and two years being to small to 
detect possible differences. 
 
6.4. Lung function from birth to ten years 
Although there is evidence that several factors influence lung function development through 
childhood, significant tracking of lung function was demonstrated by tidal flow volume 
parameters from birth to two years of age. This adds further evidence to the hypothesis that 
tracking is present from the very beginning of extra uterine life. Several other studies have 
found tracking to be evident during the first year of life (113-115), but there is to our 
knowledge no other reports including lung function measurement both at birth and at two 
years. The first years of life have been considered the most vulnerable period for insults 
affecting growth and development of the airways (187). In our study lung function 
development from birth was independent of clinical phenotype defined by rBO and AE 
indicating a strong tracking even in the first years of life. 
However, as previously discussed, we can not out rule that some environmental factors 
may induce small, but real changes in lung function since the correlation between tPTEF/tE at 
birth and two years was 0.475. However, sample sizes far larger than our 90 may be required 
to identify such. 
tPTEF/tE below median and Crs below median at birth were associated with reduced 
FEF50 and FEV1 respectively at ten years of age. Furthermore, tPTEF/tE at birth was a 
significant predictor of FEF50 at ten years. These findings indicate that tracking is evident 
from birth into school age, but the association may appear to be weaker than the tracking 
during the first two years of life and the previously reported tracking during school age (110) 
and into adolescence (111) and adulthood (112). There are several possible explanations for 
this discrepancy. First, at birth lung function measurements were performed by tidal flow 
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volume loops and passive respiratory mechanics. It is not known exactly what the tidal flow 
volume loop parameter tPTEF/tE represents, but it is assumed that “timing of PTEF is due to an 
interaction between the mechanical properties of the lungs and airways on one hand and 
central control of breathing on the other” (63). Crs and Rrs represent mechanical properties 
of the respiratory system. At ten years, lung function was measured by forced expiratory flow 
volume loops and the parameters derived represent airway calibre of the large (FEV1) and 
smaller (FEF50) airways as well as lung volume (FVC). Although tPTEF/tE has been found to 
correlate with FEV1 and FEF50 (60;66;75) we are actually comparing indices that at least 
partly represent different qualities of the airways. In addition, although measurement of lung 
function in infancy and school age is reproducible, it does show variation. Most studies report 
a CV of about 25% for tPTEF/tE (60;66;70;71). The normal variation of FEV1 has been reported 
to be up to 5% within a day and up to 12% from week to week in healthy adults (188). This 
illustrates the problems of comparing results obtained by different methods at different time 
points. This obstacle can partly be overcome by calculating z-scores (118), or group the 
children according to quartiles (189) as has been done in the ECA study. 
A second possible explanation for discrepancy in tracking the first years of life and 
from birth to school age is that lung function is modulated from birth to school age by factors 
not identified. Previous studies exploring the association between lung function in infants and 
in school age have provided conflicting results when the children were categorized according 
to wheezing phenotype (18;117). However, in a recently published study children with 
V’max,FRC in the lowest quartile at two months of age had significantly reduced FEV1, FEF25-75, 
and FEV1/FVC at both 11, 16 and 22 years of age (189), and a significant correlation 
coefficient (Pearsons r) of about 0.35 was found between infant V’max,FRC and FEF25-75 and 
FEV1/FVC at the tree time points.   
 
 65
6.5. Lung function at birth and asthma later in childhood 
Our finding of significant reduced lung function at birth in children with asthma ever as well 
as current asthma (paper II) at ten years extends previous findings of an association between 
reduced lung function at birth and respiratory illness during the first years of life. Several 
studies, including one from our own cohort, have demonstrated reduced tPTEF/tE to increase 
the risk of wheeze associated lower respiratory tract illness in the first years of life 
(160;161;165;184) as well as doctors diagnosed asthma by two years (116). Furthermore, 
reduced Crs at one month of age has been associated with persistent wheezing the first two 
years of life (163) and reduced V’max,FRC have been found to precede wheeze during the first 
years of life (162-164;184). These studies support our finding of reduced tPTEF/tE at birth in 
children with the both rBO and AE by two years of age, a sub sample of children with the 
highest prevalence of positive SPT and use of inhaled corticosteroids by two years (paper III), 
and increased risk of wheeze as well as atopic diseases in school age (20). 
Few studies that have explored the association of early infant lung function and lower 
respiratory tract illness further on to school age (18;117). Both included measurement of 
infant lung function by the RTC technique and the results have been conflicting with only one 
study (117) finding an association between reduced V’max,FRC and wheeze, but not asthma, at 
six and 11 years of age. 
The inconsistency of our results with previous findings may be explained by 
methodological differences. Whereas V’max,FRC is thought to reflect airway calibre, tPTEF/tE is 
believed to be a complex measure of lung function including airway calibre, mechanical 
properties of the airway system (60;73;75) as well as respiratory control (72). Direct 
comparison between these two parameters of lung function (as well as Crs) is therefore not 
feasible. Although small airway calibre shortly after birth may be a risk factor for obstructive 
airway disease in the first years of life, the findings in paper II suggest that other 
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characteristics of the respiratory system at birth identify infants at increased risk of asthma in 
school age. The results further suggest that markers of increased risk of asthma in school age 
are detectable already at birth. 
Another methodological difference that may explain the discrepancy is the sample 
size: our cohort included 614 children with lung function measures at birth as well as 10 
years, a population sample of more than three times the Perth cohort (117) and almost five 
times the Tucson cohort (18). Thus, the power to detect associations was improved compared 
to the previous studies. The adjusted ORs for current asthma and asthma ever are comparable 
with those previously reported for a family history of asthma (190). However, the clinical 
implication of reduced lung function at birth on an individual level is still unsettled. As 
previously discussed, the inter- and intra individual variation in tPTEF/tE is well known (167) 
and the positive predictive value for later asthma was low (14-31%) for all cut off values for 
tPTEF/tE as well as Crs. Thus, our data do not support the use of lung function measurements 
by tidal flow volume loops or respiratory mechanics as screening tests at birth for the risk of 
subsequent asthma. This conclusion is further supported by the fact that few measures have 
proven effective in preventing the development of asthma in children at risk and the 
measurement of lung function by these techniques are time consuming. However, lung 
function measurements in infancy provide a unique opportunity to assess possible modifying 
environmental effects upon, not only immunological or clinical disease expression, but also 
physiological development through childhood. 
 
6.6. Strengths and limitations 
Strengths
The ECA study is a prospective birth cohort study including detailed questionnaires every six 
months during the first two years of life and follow up at 10 years of age. It was designed to 
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investigate asthma and factors associated with asthma development during childhood, with an 
emphasis on environmental exposure. It contains a well characterized population of mainly, 
but not exclusively, Norwegian ethnicity.  The longitudinal design with inclusion early in life 
and later follow up reduces the risk of recall bias and misclassification thereby increasing the 
level of evidence (191). The follow up rate of 77% and the children included being 
representative for the total ECA cohort at birth makes inclusion bias unlikely. 
The ECA cohort includes the largest population of children with lung function 
measurements in infancy known to date. The sample size, and the fact that our findings are 
supported by other studies make a type I error in paper II and a type II error in paper IV 
unlikely. 
At ten years the definition of asthma ever was based on a combination of symptoms, 
medication and clinical diagnosis and not only on one of these criteria as has been customary. 
For the definition of current asthma an objective measure of AHR was included as well. We 
believe that these more comprehensive definitions reduce the risk of misclassifications 
thereby increasing the validity of our findings. However, we also included the core questions 
from the standardized ISAAC questionnaires, making it possible to compare our results with 
other studies. 
All the study doctors and technicians involved in the ten years assessment where 
blinded to the results of the lung function measurements at birth and two years of age as well 
as other results from ECA-1.  
Limitations
AHR has been found to be associated with reduced growth of lung function during childhood 
and adolescence (97;133;135). In one prospective study AHR at one month of age was 
associated with reduced levels of FEV1 and FVC as well as doctors diagnosed asthma at six 
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years of age (192). The ECA study did not include measurement of AHR early in life or at 
two years of age and it was therefore not possible to adjust for this factor in our analyses. 
However, there is currently no standardised method for AHR measurements in early 
childhood, and in particular not for the TFV or passive respiratory mechanics measurements 
employed in early childhood in the present study.  
As previously discussed the study sample in paper III may have been too small to 
identify small, but real effects of different factors on lung function development by two years. 
Due to the previously described intra- and inter individual variation of tidal flow volume 
measurements one would expect the somewhat small study sample to further reduce our 
power to detect tracking from birth to two years of age. However, despite these limitations we 
found significant tracking of lung function the first two years of life.  
 
6.7. Future perspectives 
The results of the papers included in the present thesis raises two main questions. First: Why 
do some children have reduced lung function at birth making them more susceptible to lower 
respiratory tract illness during childhood? Tobacco smoke during pregnancy, parental atopy 
and maternal lower respiratory tract infections during pregnancy have, as previously 
discussed, been associated with reduced lung function early in life, but these factors can only 
partly explain the impaired lung function observed among some infants. Whether the factors 
decisive for impaired intra uterine lung function evolution are primary genetic, environmental 
or a combination of these can not be decided upon by the present knowledge and needs 
further investigation. New studies addressing this question should ideally recruit mothers 
ahead of pregnancy and include close follow up of the mothers during pregnancy and of the 
children after birth. These studies are challenging to conduct, but identifying these risk factors
 69
may make preventive measures possible either on a population level or in children at risk of 
developing asthma. 
The second question that the present thesis raises is whether lung function at birth is a 
predictor for obstructive airway disease even in adult life? The association between lower 
respiratory tract illness in childhood and reduced lung function and increased risk of 
obstructive pulmonary disease in adult life has been known for many years (193). The 
findings presented in the present thesis give evidence to the hypothesis that children with 
lower respiratory tract illness during childhood have reduced lung function already at birth 
and, although smoking has been identified as the major risk factor for decline in lung function 
and adult chronic obstructive pulmonary disease, the question of how much of adult 
obstructive airway disease can actually be attributed to reduced lung function at birth (and 
thereby prenatal factors) is still to be answered. To answer this question infants included in 
birth cohorts with lung function measurement shortly after birth, like the ECA study, have to 
be followed into adult life. 
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7.  CONCLUSION 
 
Based upon the results of the included papers and previous knowledge in the research areas 
explored in the present thesis the following conclusions can be drawn on the specific research 
questions: 
 
1. Among schoolchildren in Oslo the lifetime prevalence of asthma and current asthma 
was 20.2% and 11.1% respectively. The findings indicate a substantial increase in 
prevalence when compared with surveys conducted 10 years earlier. 
2. Children with current asthma at ten years of age had reduced lung function by FEV1 
and FEF50 at ten years as well as at birth and children with asthma ever have reduced 
lung function at birth. 
3. Lung function development from birth to ten years of age is negatively associated with 
current asthma at ten years and maternal smoking during pregnancy. LRIs the first two 
years of life had no significant impact on lung function development in contrast to 
previous hypotheses. 
Lung function development by tPTEF/tE from birth to two years of age was not 
influenced by clinical phenotype by two years (presence of rBO and/or AE) or 
maternal smoking during pregnancy in our relatively small population size. 
4. Lung function at birth was associated with lung function at two years as well as at ten 
years of age. tPTEF/tE at birth correlated reasonably well with tPTEF/tE at two years of 
age and lung function tracking was present the first two years of life independent of 
clinical phenotype by two years. tPTEF/tE at birth was likewise a significant predictor of 
lung function at ten years of age and reduced levels of tPTEF/tE and Crs at birth was 
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associated with impaired lung function at ten years of age. The findings add further 
evidence to the hypothesis that tracking of lung function starts very early in life 
5. Reduced lung function at birth was a risk factor for asthma by 10 years and associated 
with the clinical phenotype by two years including both rBO and AE. The value of 
lung function measurements at birth on an individual level was limited due to the low 
predictive value, whereas the value in a prospective study is much greater providing a 
basis for understanding natural development and environmental influences in disease 
development. 
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ERRATA
The following spelling errors have been corrected since submission to the doctoral committee: 
Page 9 line 13 ”cocurrent” has been substituted with “concurrent” 
Page 9 line 20 “is” has been deleted 
Page 10 line 6 ”mid” has been substituted with ”since” 
Page 58 line 21 “an” has been deleted 
Page 63 line 24 “adolescent” has been substituted with “adolescence” 
Page 64 line 4 and 6 “represents” has been substituted with “represent” 
Page 66 line 15 “facts” has been substituted with “fact” 
Page 68 line 1 “included” has been substituted with “include” 
Page 70 line 20 “reasonable” has been substituted with “reasonably” 
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